Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$391M |
| 2 |
Amazon
AMZN
|
+$361M |
| 3 |
Microsoft
MSFT
|
+$358M |
| 4 |
Meta Platforms (Facebook)
META
|
+$196M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$171M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$141M |
| 3 |
Eli Lilly
LLY
|
+$125M |
| 4 |
Waste Management
WM
|
+$124M |
| 5 |
McDonald's
MCD
|
+$112M |
Sector Composition
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Communication Services | 11.57% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCXI
2301
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.43M | ﹤0.01% |
106,800
-3,900
| -4% | -$52.2K |
|
2302
American Well
AMWL
$106M
| $1.43M | ﹤0.01% |
+5,680
| New | +$1.43M |
|
2303
Syndax Pharmaceuticals
SNDX
$1.36B
| $1.43M | ﹤0.01% |
83,100
+9,000
| +12% | +$155K |
|
2304
Community Trust Bancorp
CTBI
$1.04B
| $1.43M | ﹤0.01% |
35,290
-1,000
| -3% | -$40.4K |
|
2305
PetMed Express
PETS
$56.4M
| $1.42M | ﹤0.01% |
44,700
-1,600
| -3% | -$51K |
|
2306
Liberty Latin America Class A
LILA
$1.51B
| $1.42M | ﹤0.01% |
102,600
+2,600
| +3% | +$36K |
|
2307
Luxfer Holdings
LXFR
$358M
| $1.42M | ﹤0.01% |
63,900
+1,500
| +2% | +$33.4K |
|
2308
A10 Networks
ATEN
$1.26B
| $1.42M | ﹤0.01% |
126,200
+11,700
| +10% | +$132K |
|
2309
MediaAlpha
MAX
$692M
| $1.42M | ﹤0.01% |
+33,700
| New | +$1.42M |
|
|
GTHX
2310
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.42M | ﹤0.01% |
64,500
| – | – |
|
2311
i3 Verticals
IIIV
$720M
| $1.41M | ﹤0.01% |
+46,800
| New | +$1.41M |
|
2312
National Research Corp
NRC
$366M
| $1.41M | ﹤0.01% |
30,800
-1,000
| -3% | -$45.9K |
|
|
BFS
2313
Saul Centers
BFS
$779M
| $1.41M | ﹤0.01% |
31,083
-1,000
| -3% | -$45.5K |
|
|
SRG
2314
Seritage Growth Properties
SRG
$251M
| $1.41M | ﹤0.01% |
76,638
-6,500
| -8% | -$120K |
|
2315
Myers Industries
MYE
$602M
| $1.41M | ﹤0.01% |
67,100
-1,800
| -3% | -$37.8K |
|
|
CFB
2316
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.41M | ﹤0.01% |
102,500
-4,900
| -5% | -$67.4K |
|
2317
OneSpaWorld
OSW
$2.24B
| $1.41M | ﹤0.01% |
145,300
+22,700
| +19% | +$220K |
|
2318
HCI Group
HCI
$2.31B
| $1.4M | ﹤0.01% |
14,100
-500
| -3% | -$49.7K |
|
2319
Nicolet Bankshares
NIC
$2B
| $1.4M | ﹤0.01% |
19,900
-800
| -4% | -$56.3K |
|
|
TPC
2320
Tutor Perini Corporation
TPC
$3.29B
| $1.4M | ﹤0.01% |
101,000
+8,100
| +9% | +$112K |
|
2321
Cantaloupe
CTLP
$789M
| $1.39M | ﹤0.01% |
+117,500
| New | +$1.39M |
|
2322
Carriage Services
CSV
$652M
| $1.39M | ﹤0.01% |
37,671
-1,000
| -3% | -$37K |
|
2323
Scholar Rock
SRRK
$3B
| $1.39M | ﹤0.01% |
48,200
-5,600
| -10% | -$162K |
|
2324
Ecovyst
ECVT
$1.05B
| $1.39M | ﹤0.01% |
90,600
-2,300
| -2% | -$35.3K |
|
|
IGMS
2325
DELISTED
IGM Biosciences
IGMS
| $1.38M | ﹤0.01% |
16,600
| – | – |
|